2020, Number 4
<< Back Next >>
Rev Mex Pediatr 2020; 87 (4)
Spotted rocky mountain fever in children. Clinical and histopathological correlation
Ungson-García MG, Gómez-Rivera N, Gómez-Jiménez IA, García-Zarate MG, Gómez-Figueroa CO, Villalobos-García L
Language: Spanish
References: 17
Page: 142-145
PDF size: 309.95 Kb.
ABSTRACT
Two clinical cases of Rocky Mountain spotted fever in children with different clinical course are presented. One patient had a satisfactory evolution, since the specific treatment was initiated within the first five days of initiating the symptoms; while the other patient had a fatal outcome, with necrosis and gangrene in lower extremities. In both cases, diagnosis was confirmed by skin biopsy using the technique of Pinkerton.
REFERENCES
Gómez N, Álvarez G, García M, Fonseca I, Cano M, Villalobos L et al. Fiebre manchada de las Montañas Rocosas en niños. Informe de 18 casos. Rev Mex Pediatr. 2009; 76(6): 245-250.
Gómez N, Gómez I, Fonseca I, García M, Gómez O, Villalobos L et al. Factores relacionados con la mortalidad en niños con fiebre manchada de las montañas rocosas: análisis de 14 años en Sonora, México. Rev Mex Pediatr. 2019; 86(1): 8-12.
Walker D, Raoult D. Rickettsia rickettsii and other spotted fever group Rickettsiae. In: Mandell, Bennett, & Dolin. Principles and practice of infectious diseases. 6th edition; 2005, pp. 2287-2295.
Foley J, Tinoco L, Rodriguez M, Estrada J, Fierro M, Mattar E et al. Unbiased Assessment of abundance of Rhipicephalus sanguineus senso lato Ticks. Exposure to spotted fever Group Rickettsia and Risk in Mexicali, México. Am J Trop Med Hyg. 2019; 101: 22-32.
Tull R, Ahn C, Daniel A, Yosipovitch G, Strowd L. Retrospective study of Rocky Mountain spotted fever in children. Pediatr Dermatol. 2017; 34: 119-123.
Luna G. Manual of histologic staining methods of the armed forces institute of pathology. 3rd ed., HT (ASCP); 1960, pp. 237.
Simons J, Gentzkow C. Laboratory methods of the United States Army. 5th ed. Philadelphia, Penn., Lea and Febiger; 1944, pp. 572.
Dellinger R. Surviving sepsis campaing. international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2008; 36: 296-227.
Gómez N, Fonseca I, García M, Gómez C, Villalobos L. Contraste entre dos esquemas de antibióticos en niños con choque séptico por “fiebre manchada de las Montañas Rocosas”. Rev Mex Pediatr. 2014; 81(6): 204-208.
Heinzen R, Hayes S, Peacock M, Hackstad T. Directional actin polymerization associated with spotted fever group rickettsia infection of Vero cells. Infect Immun. 1993; 61: 1926-1935.
Burgdorfer W, Anacker R, Bird R, Bertram D. Intranuclear growth of Rickettsia rickettsii. J Bacteriol. 1968; 96: 1415-1418.
Raoult D, La Scola B, Enea M. A flea-associated rickettsia pathogenic for humans. Emerg Infect Dis. 2001; 7: 73-81.
Cunha B. Antibiotic essentials, 7th ed. Royal Oak, MI: Physicians Press, 2008, pp. 442-443.
Cunha B. Typhoid fever: the temporal relations of key clinical diagnostic points. Lancet Infect Dis. 2006; 6: 318-320.
Broze G. Tissue factor pathway inhibitor and the current concept of blood coagulation. Blood Coagul Fibrinolysis. 1995; 6: 7-13.
Aird W. Endothelial cell heterogeneity. Crit Care Med. 2003; 31: S221-229.
Duboscq C. Rol de la heterogeneidad endotelial en la regulación de la hemostasia. Acta Bioquim Latinome. 2006; 40(3): 317-325.